Сŷ��Ƶ

New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease

Сŷ��Ƶ Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development

CoverScan, Сŷ��Ƶ’s multi-organ MRI technology, has been nominated for the 2024 Prix Galien USA award for Best Digital Health Solution.

New Published Data Show Reproducibility and Utility of Сŷ��Ƶ’s MRI in Patients With Metabolic Liver Disease

Dr Rajarshi Banerjee joins Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development manager in this episode of the AWS Health Innovation Podcast.

New Study Uncovers Unprecedented Links Between Liver and Heart Health and the Importance of Doctors' Prioritizing Liver Health to Promote Heart Health

Сŷ��Ƶ and BluMaiden Biosciences Pte. Ltd. (“BluMaiden BioSciences”) Form Strategic Collaboration to Introduce Novel Insights into Clinical Trials

Сŷ��Ƶ Completes $19 Million Second Close of Series C Funding Led by Oppenheimer & Co. Inc. (“Oppenheimer”)

Сŷ��Ƶ Completes $36 Million First Close of Series C Funding Led by Oppenheimer Holdings